Approved Therapeutics/Drug Candidates,
Bioactive Small Molecule Alphabetical Index,
Bioactive Small Molecules,
Biochemicals and Reagents,
Cell Biology,
Cell Signaling and Neuroscience,
Chemical Structure,
Chromatography,
Drugs of Abuse,
Excitatory Amino Acids - Opiod Agonists,
Forensic and Veterinary Standards,
GPCR Modulators,
GPCR Proteins, Modulators and Antibodies,
H,
Membrane Protein Biology Tools,
Morphine,
Neurobiology,
Neuroscience,
Opioid Agonists,
Opioids,
Pharmacologicals,
Proteins and Derivatives
More...
InChI Key
OJHZNMVJJKMFGX-BWCYBWMMSA-N
drug control
USDEA Schedule II; Home Office Schedule 2; stupéfiant; kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
solubility
H2O: 62 mg/mL
ethanol: soluble
originator
Abbott
Description:
Biochem/physiol Actions
μ opioid receptor agonist; narcotic analgesic and antitussive.
Features and Benefits
This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Safety:
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter